4 news items
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCEĀ®)
ARVN
PFE
16 May 24
and for 3 months after the last dose. Advise females to inform their healthcare provider of a known or suspected pregnancy. Advise women
Arvinas to Present at Upcoming Investor Conferences
ARVN
2 May 24
investor conferences: BofA Securities 2024 Healthcare Conference on Tuesday, May 14 at 3:00 p.m. PT in Las
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
the FDA's response. Driven by favorable healthcare economics combined with patient satisfaction and demand, we expect rapid adoption pending
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
the FDA's response. Driven by favorable healthcare economics combined with patient satisfaction and demand, we expect rapid adoption
- Prev
- 1
- Next